FDA Approved: ARIPIPRAZOLE — Original Application (Exelan Pharmaceuticals, Inc.)

View source ↗

Summary

FDA approved a generic aripiprazole tablet under ANDA205064 for Exelan Pharmaceuticals, authorizing sale for the same indications as the brand product Abilify.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Autism Spectrum Disorder
• Bipolar Disorder
• Major Depressive Disorder
• Schizophrenia

Drugs mentioned

• ARIPIPRAZOLE (Aripiprazole)

Snippet

ORIG AP for ARIPIPRAZOLE (ARIPIPRAZOLE)